Founded in 2019 and headquartered in Houston, Texas, Animal Life Sciences is dedicated to developing nutritional and pharmaceutical treatments for pets, specifically cats and dogs. Leveraging cutting-edge human cancer technologies, the company focuses on the licensing, development, and commercialization of safe and effective treatments. Their core mission is to improve pet health by translating advanced human medical research into veterinary applications.
Animal Life Sciences was established by a team of leading scientists, clinicians, and executives with extensive experience in drug discovery and product commercialization. The company has made significant strides in adapting human cancer treatments for veterinary use, showcasing their innovative approach. Their work has the potential to revolutionize pet healthcare, offering new hope for treating serious conditions in animals.
